Human anti-amyloid beta peptide antibody and fragment of said antibody
US8222002B2 · kind B2 · utility
2Cited by
5References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 2, 2010 |
| Grant date | Jul 17, 2012 |
| Priority date | — |
| Expiry date | Jan 8, 2031 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/2821
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A human anti-amyloid β peptide (hereinafter referred to as “Aβ”) antibody that binds to Aβ to thereby inhibit aggregation of Aβ molecules, and a fragment of said antibody are provided. The antibody and a fragment thereof according to the present invention, comprising a variable region of a human-derived anti-Aβ antibody, strongly reacts with Aβ to thereby inhibit its aggregation and hence may be used as a medicament for the prophylaxis and treatment of Alzheimer dementia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.